0001127602-24-017571.txt : 20240604
0001127602-24-017571.hdr.sgml : 20240604
20240604141521
ACCESSION NUMBER: 0001127602-24-017571
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240531
FILED AS OF DATE: 20240604
DATE AS OF CHANGE: 20240604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAVIZZO-MOUREY RISA J
CENTRAL INDEX KEY: 0001034465
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06571
FILM NUMBER: 241017149
MAIL ADDRESS:
STREET 1: GE HEALTHCARE TECHNOLOGIES INC.
STREET 2: 500 W. MONROE ST.
CITY: CHICAGO
STATE: IL
ZIP: 60661
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merck & Co., Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 221918501
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
FORMER COMPANY:
FORMER CONFORMED NAME: Merck & Co. Inc.
DATE OF NAME CHANGE: 20091103
FORMER COMPANY:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-05-31
0000310158
Merck & Co., Inc.
MRK
0001034465
LAVIZZO-MOUREY RISA J
MERCK & CO., INC.
126 EAST LINCOLN AVENUE
RAHWAY
NJ
07065
1
0
Common Stock
1000
D
Phantom Stock
2024-05-31
4
A
0
1752.4295
125.54
A
Common Stock
1752.4295
12120.4279
D
1-for-1
Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
Holdings include shares acquired in dividend reinvestment transactions.
/s/ Kelly E. W. Grez as Attorney-in-Fact for Risa Lavizzo-Mourey
2024-06-04